Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2011 Jun 7;7(9):507-16.
doi: 10.1038/nrendo.2011.77.

GLP-1 and energy balance: an integrated model of short-term and long-term control

Jason G Barrera  1 , Darleen A Sandoval, David A D'Alessio, Randy J Seeley
Affiliations
Review

GLP-1 and energy balance: an integrated model of short-term and long-term control

Jason G Barrera et al. Nat Rev Endocrinol. .

Abstract

Glucagon-like peptide 1 (GLP-1), a peptide secreted from the intestine in response to nutrient ingestion, is perhaps best known for its effect on glucose-stimulated insulin secretion. GLP-1 is also secreted from neurons in the caudal brainstem, and it is well-established that, in rodents, central administration of GLP-1 potently reduces food intake. Over the past decade, GLP-1 has emerged not only as an essential component of the system that regulates blood glucose levels but also as a viable therapeutic target for the treatment of type 2 diabetes mellitus. However, although GLP-1 receptor agonists are known to produce modest but statistically significant weight loss in patients with diabetes mellitus, our knowledge of how endogenous GLP-1 regulates food intake and body weight remains limited. The purpose of this Review is to discuss the evolution of our understanding of how endogenous GLP-1 modulates energy balance. Specifically, we consider contributions of both central and peripheral GLP-1 and propose an integrated model of short-term and long-term control of energy balance. Finally, we discuss this model with respect to current GLP-1-based therapies and suggest ongoing research in order to maximize the effectiveness of GLP-1-based treatment of obesity.

PubMed Disclaimer

Conflict of interest statement

Competing interests

D. A. Sandoval declares an association with the following company: Ethicon. D. A. D’Alessio declares an association with the following companies: Amylin, Johnson and Johnson, MannKind, Merck, Novo Nordisk, Sanofi-Aventis, Takeda. R. J. Seeley declares an association with the following companies: Alkermes, Amylin, Eli Lilly, Johnson and Johnson, MannKind, Merck, Novo Nordisk, Roche, Zafgen. See the article online for details of the relationships. J. G. Barrera declares no competing interests.

Figures

Figure 1
Figure 1
Model of GLP-1 physiology. Nutrient ingestion stimulates intestinal L-cell secretion of glucagon-like peptide 1 (GLP-1), which activates local GLP-1 receptors (GLP1R) to initiate afferent vagal neurotransmission to the hindbrain. These vagal afferent signals, combined with those initiated by gastric distension, may activate hindbrain GLP-1-producing neurons, which in turn activate hindbrain GLP1R, as well as other hindbrain neurons to produce efferent signals leading to decreased meal size. In addition, signaling from hindbrain GLP-1-producing neurons to hypothalamic targets promotes decreased fat mass.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Moran TH, Kinzig KP. Gastrointestinal satiety signals II. Cholecystokinin. Am J Physiol Gastrointest Liver Physiol. 2004;286:G183–G188. - PubMed
    1. Benoit SC, Clegg DJ, Seeley RJ, Woods SC. Insulin and leptin as adiposity signals. Recent Prog Horm Res. 2004;59:267–285. - PubMed
    1. Holst JJ. The physiology of glucagon-like peptide 1. Physiol Rev. 2007;87:1409–1439. - PubMed
    1. Baggio LL, Drucker DJ. Biology of incretins: GLP-1 and GIP. Gastroenterology. 2007;132:2131–2157. - PubMed
    1. Parker HE, Reimann F, Gribble FM. Molecular mechanisms underlying nutrient-stimulated incretin secretion. Expert Rev Mol Med. 2010;12:e1. - PubMed

MeSH terms